2.85
4.04%
-0.12
Handel nachbörslich:
2.87
0.02
+0.70%
Organogenesis Holdings Inc Aktie (ORGO) Neueste Nachrichten
Organogenesis reports Q1 EPS (2c), consensus (3c) - TipRanks.com - TipRanks
TipRanks
Organogenesis Holdings Inc (ORGO) looking to reclaim success with recent performance – Sete News - SETE News
SETE News
Organogenesis Holdings Inc (ORGO) stock analysis: A simple moving average approach – US Post News - US Post News
US Post News
Shareholders in Organogenesis Holdings (NASDAQ:ORGO) are in the red if they invested a year ago - Yahoo Movies UK
Yahoo Movies UK
Organogenesis Holdings First Quarter 2024 Earnings: Beats Expectations - Simply Wall St
Simply Wall St
Organogenesis Holdings First Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Yahoo Finance
Organogenesis (NASDAQ:ORGO) Issues Earnings Results, Beats Estimates By $0.01 EPS - MarketBeat
MarketBeat
Organogenesis Holdings Inc. Reports First Quarter 2024 Results: A Close Look at Financial ... - Yahoo Finance
Yahoo Finance
Organogenesis Holdings Inc. (NASDAQ:ORGO) Q1 2024 Earnings Call Transcript - Yahoo Finance
Yahoo Finance
Earnings call: Organogenesis exceeds Q1 expectations, eyes ReNu progress - Investing.com
Investing.com
Organogenesis (ORGO) Q1 2024 Earnings Call Transcript
The Motley Fool
Skin Replacement and Substitute Market Size (Revenue) | Acelity L.P. Inc., MiMedx Group Inc., Organogenesis Inc. - Motions Online
Motions Online
Organogenesis (ORGO) to Release Earnings on Thursday - Defense World
Defense World
Organogenesis (ORGO) to Release Earnings on Thursday - Defense World
Defense World
The Organogenesis Holdings (NASDAQ:ORGO) Share Price Is Up 330% And Shareholders Are Delighted - Yahoo Movies Canada
Yahoo Movies Canada
Corbus Pharmaceuticals (CRBP) Catches Eye: Stock Jumps 7.3% - Yahoo Movies UK
Yahoo Movies UK
Organogenesis Phase 3 ReNu OA study meets primary endpoint (NASDAQ:ORGO) - Seeking Alpha
Seeking Alpha
Organogenesis (ORGO) Scheduled to Post Quarterly Earnings on Thursday - MarketBeat
MarketBeat
Organogenesis achieves primary endpoint in Phase 3 trial of ReNu - TipRanks.com - TipRanks
TipRanks
Shareholders Should Be Pleased With Organogenesis Holdings Inc.'s (NASDAQ:ORGO) Price - Simply Wall St
Simply Wall St
Are Organogenesis Holdings Inc (ORGO) shares a good deal now? – US Post News - US Post News
US Post News
Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024
GlobeNewswire Inc.
Organogenesis Announces Favorable Court Ruling Dismissing Securities Fraud Case
GlobeNewswire Inc.
Organogenesis Holdings Full Year 2023 Earnings: Misses Expectations - Yahoo Finance
Yahoo Finance
Why Organogenesis Holding Stock Plummeted by 18% Today
The Motley Fool
Why Organogenesis Holding Stock Plummeted by 18% Today - The Motley Fool
The Motley Fool
Organogenesis (ORGO) Q4 2023 Earnings Call Transcript
The Motley Fool
Organogenesis (ORGO) Reports Break-Even Earnings for Q4
Zacks Investment Research
Organogenesis (ORGO) Q4 2023 Earnings Call Transcript - The Motley Fool
The Motley Fool
Organogenesis Holdings Inc. to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference
GlobeNewswire Inc.
Organogenesis Holdings Inc. to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic ... - Yahoo Finance
Yahoo Finance
Foghorn Therapeutics Inc. (FHTX) Moves 22.7% Higher: Will This Strength Last?
Zacks Investment Research
Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 29, 2024
GlobeNewswire Inc.
Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 29, 2024 - GlobeNewswire
GlobeNewswire
HRMY: 4 Biotech Stocks With Massive Buy Potential - StockNews.com
StockNews.com
Are You Looking for a Top Momentum Pick? Why Organogenesis (ORGO) is a Great Choice
Zacks Investment Research
Have Organogenesis Holdings Insiders Been Selling Stock? - Simply Wall St
Simply Wall St
ORGO: 3 Biotech Stocks to Keep an Eye on in 2024 - StockNews.com
StockNews.com
Best Momentum Stocks to Buy for January 5th
Zacks Investment Research
New Strong Buy Stocks for January 5th
Zacks Investment Research
Organogenesis (ORGO) is a Great Momentum Stock: Should You Buy?
Zacks Investment Research
Why Reneo Pharmaceuticals Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Benzinga
Meta To Rally Over 18%? Here Are 10 Top Analyst Forecasts For Wednesday
Benzinga
VRTX: 3 Biotech Stock Buys to Supercharge Your Portfolio - StockNews.com
StockNews.com
The Zacks Analyst Blog Highlights Organogenesis, Riskified, Hooker Furniture, Stoneridge and VirTra
Zacks Investment Research
5 Reasons Why Small-Cap Stocks Can Surge in 2024: 5 Top Picks
Zacks Investment Research
ORGANOGENESIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Organogenesis Holdings, Inc. on Behalf of ... - Business Wire
Business Wire
Here Is Why Bargain Hunters Would Love Fast-paced Mover Organogenesis (ORGO)
Zacks Investment Research
Organogenesis (ORGO) Q3 2023 Earnings Call Transcript - The Motley Fool
The Motley Fool
BMRN: 3 Brilliant Biotech Stocks to Buy for Your Portfolio - StockNews.com
StockNews.com
Kapitalisierung:
|
Volumen (24h):